Needham & Company Maintains a 'Hold' on Teva Pharma (TEVA); European Generics Are Bottoming & Downside Risks Shrink
Tweet Send to a Friend
Needham & Company maintains a 'Hold' on Teva Pharma (NASDAQ: TEVA).
Analyst, Elliot Wilbur, said, "TEVA did what the ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
Analyst, Elliot Wilbur, said, "TEVA did what the ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
